PROSTATIC ARTERY EMBOLIZATION MARKET ANALYSIS (2020-2027)

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
ARTERY EMBOLIZATION MARKET ANALYSIS (2020-2027)

• Prostatic Artery Embolization Market - Global
  Industry Insights, Trends, Outlook, and
  Opportunity Analysis 2020-2027

3

• Prostatic artery embolization is a short invasive
  treatment used to treat prostate gland
  enlargement due to benign prostate hyperplasia
  (BPH) and its associated urinary tract symptoms.
  Benign prostate hyperplasia is a non-malignant
  enlargement of the prostate gland and mostly
  found in men. Prostatic artery embolization is
  performed when prostate tumor grows bigger and
  the patient may have uncontrollable urinary tract
  symptoms. Prostatic artery embolization is an
  alternative treatment for surgical procedures
  which is performed through interventional
  radiology. In a prostatic artery embolization
  procedure, the interventional radiologist shrinks
  the prostate by treating blood vessels in the
  prostate through an incision in the patients
  upper thigh.

4

• Global Prostatic Artery Embolization Market-
  Drivers
• Prostatic artery embolization is more effective
  than surgical prostate gland enlargement.
  Prostatic artery embolization has several
  advantages compared to surgical procedures such
  as less morbidity, fast recovery. Moreover, the
  prostatic artery embolization is short invasive
  treatment than traditional prostatic treatment.
  Therefore, several healthcare facilities are
  implementing prostatic artery embolization
  treatment due to its efficiency and safety.
  According to the University of California and San
  Francisco (UCSF), Department of Radiology and
  Bio-medical Imaging, there is a growing adoption
  of prostatic artery embolization procedures among
  physicians in the U.S. due to the procedures
  less invasive nature compared to traditional
  surgical procedures. These factors are expected
  to support global prostatic artery embolization
  market growth during the forecast period.

5

• Global Prostatic Artery Embolization Market-
  Impact of COVID-19
• The COVID-19 pandemic has impacted growth of
  various markets, and it is also expected to
  hamper the growth of the global prostatic artery
  embolization market during the forecast period.
  Moreover, implementation of nationwide lockdown
  in several countries and safety precautions
  suggested by World Health Organization to
  decrease the risk of spread of COVID-19 while
  performing surgical procedures it has become very
  difficult to conduct surgical procedures in
  patients.

6

• Global Prostatic Artery Embolization Market-
  Restraints
• Prostatic artery embolization procedure is
  accompanied with Post-PAE Syndrome in patients.
  In Post-PAE syndrome, patients may experience
  nausea, pelvic pain, and frequent urination which
  may refrain them from opting for this treatment
  option. Moreover, according to U.S National
  Library of Medicine, prostatic artery
  embolization procedures involves use of
  ionization radiation with dose range of
  approximately 47 mSv, which is roughly equivalent
  to increase lifetime cancer risk in patient
  population with average age of 65 in men. These
  factors are expected to restrain the global
  prostatic artery embolization market.

7

• Global Prostatic Artery Embolization Market-
  Regional Analysis
• On the basis of regions, the global prostatic
  artery embolization market is segmented into
  North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. The North
  America Prostatic artery embolization market is
  expected to exhibit significant growth due
  pharmaceutical medical device companies focusing
  on new product development in global prostatic
  artery embolization market. For instance, in 2017
  Merit Medical Systems Inc. received an approval
  for its Merits Embosphere from the Food Drug
  Administration (FDA) for Prostatic artery
  embolization, a non-surgical treatment for men
  who suffer from Benign Prostate Hyperplasia (BPH).

8

• Moreover, the Europe Prostatic artery
  embolization market is expected to witness
  significant growth due to various actions taken
  by regulatory bodies across the region. In 2018,
  the United Kingdom National Institute of Health
  and Care Excellence, which provides guidance and
  advice related to health, stated that the
  prostatic artery embolization procedure is safe
  and provides clinically stable results in
  treatment of prostate enlargement due to Benign
  Prostate Hyperplasia (BPH).

9

• Global Prostatic Artery Embolization Market-
  Competitive Landscape
• Key operating players in the global prostatic
  artery embolization market are Mentice AB, Merit
  Medical Systems, Inc, Boston Scientific
  Corporation, Siemens Healthineers AG, GE
  Healthcare, Terumo Corporation, Embolx, Inc., and
  QXMedical, LLC.
• Key Developments-
• In 2018, Embolx, Inc., a medical device company,
  announced CE certification for its next
  generation of sniper balloon occlusion
  micro-catheters for treatment of enlarged
  prostate and cancerous tumors.
• In 2019, QX Medicals, a medical device company,
  acquired the rights of bioresorbable embolic
  technology developed by researchers at the
  University of Minnesota. This bioresorbable
  embolic technology is are used by interventional
  radiologist for prostatic artery embolization.

10

• Global Prostatic Artery Embolization Market-
  Taxonomy

• By Region-
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

• By Product Type-
• Microspheres
• Micro-catheters
• Guidewires
• By End User-
• Hospitals
• Ambulatory Surgical Centres
• Speciality Clinics

11

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Buy Now
• Reference https//www.coherentmarketinsights.com/
  ongoing-insight/prostatic-artery-embolization-mark
  et-4108

12
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

13
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

14

• Thank You!
• Kindly follow CMI Social Media
  Profiles for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/